We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$2.09B
Cap. Flow
-$1.4B
Cap. Flow %
-8.24%
Top 10 Hldgs %
32.24%
Holding
303
New
25
Increased
89
Reduced
109
Closed
31

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$187M
2
APH icon
Amphenol
APH
+$160M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$109M
4
FSLR icon
First Solar
FSLR
+$101M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$101M

Top Sells

Rank Stock Value
1
INDV icon
Indivior Pharmaceuticals
INDV
+$783M
2
NVDA icon
NVIDIA
NVDA
+$273M
3
AMD icon
Advanced Micro Devices
AMD
+$178M
4
CRM icon
Salesforce
CRM
+$110M
5
CDNS icon
Cadence Design Systems
CDNS
+$96.6M

Sector Composition

Rank Sector Weight
1 Technology 45.69%
2 Healthcare 18.55%
3 Financials 15.91%
4 Communication Services 12.03%
5 Consumer Discretionary 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOW icon
26
ServiceNow
NOW
$147B
$152M 0.9%
966,395
-228,960
-19% -$33.6M
ISRG icon
27
Intuitive Surgical
ISRG
$134B
$148M 0.87%
332,237
-36,714
-10% -$14.6M
MPWR icon
28
Monolithic Power Systems
MPWR
$56.2B
$147M 0.86%
178,624
+63,458
+55% +$45.8M
TER icon
29
Teradyne
TER
$51.5B
$146M 0.86%
983,476
+557,479
+131% +$70.8M
AMAT icon
30
Applied Materials
AMAT
$337B
$140M 0.83%
593,892
+74,560
+14% +$16M
REGN icon
31
Regeneron Pharmaceuticals
REGN
$81.7B
$140M 0.82%
133,031
-43,927
-25% -$42.6M
EG icon
32
Everest Group
EG
$14.3B
$134M 0.79%
350,978
+20,000
+6% +$7.56M
CYTK icon
33
Cytokinetics
CYTK
$10.1B
$133M 0.78%
2,454,665
+849,089
+53% +$51.3M
ESNT icon
34
Essent Group
ESNT
$6.13B
$132M 0.78%
2,350,000
+19,500
+0.8% +$1.09M
MKL icon
35
Markel Group
MKL
$22.1B
$129M 0.76%
81,750
+2,250
+3% +$3.49M
PGR icon
36
Progressive
PGR
$126B
$126M 0.74%
605,805
+961
+0.2% +$201K
CFLT
37
DELISTED
Confluent
CFLT
$125M 0.74%
4,224,546
+1,471,377
+53% +$42.3M
CLDX icon
38
Celldex Therapeutics
CLDX
$3.08B
$114M 0.67%
3,076,783
+17,291
+0.6% +$652K
TRV icon
39
Travelers Companies
TRV
$78.9B
$108M 0.64%
532,048
+31,500
+6% +$6.77M
ESTC icon
40
Elastic
ESTC
$8.94B
$107M 0.63%
935,369
+7,560
+0.8% +$794K
FSLR icon
41
First Solar
FSLR
$22.3B
$105M 0.62%
+463,764
New +$101M
ARM icon
42
Arm
ARM
$255B
$104M 0.62%
638,611
-92,415
-13% -$11.5M
NFLX icon
43
Netflix
NFLX
$334B
$101M 0.6%
1,497,930
-1,456,680
-49% -$91M
AXON
44
Axon Enterprise
AXON
$39.8B
$99.7M 0.59%
338,749
+161,420
+91% +$48.2M
XENE icon
45
Xenon Pharmaceuticals
XENE
$5.64B
$98.9M 0.58%
2,536,058
-76,050
-3% -$3.04M
TSLA icon
46
Tesla
TSLA
$1.42T
$98.5M 0.58%
497,672
+2,291
+0.5% +$400K
RGA icon
47
Reinsurance Group of America
RGA
$16.2B
$96.7M 0.57%
471,000
– –
SNPS icon
48
Synopsys
SNPS
$73.1B
$95.1M 0.56%
159,823
-118,809
-43% -$67.2M
BPMC
49
DELISTED
Blueprint Medicines
BPMC
$94.3M 0.56%
875,000
+10,000
+1% +$1M
AVDL
50
DELISTED
Avadel Pharmaceuticals
AVDL
$92.2M 0.54%
6,560,415
-193,257
-3% -$3.15M
1
2
3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $40.6B AUM 38.65% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Polar Capital Holdings's Q2 2024 Portfolio in Review

As of Q2 2024, Polar Capital Holdings held 303 positions worth $17B, down 11% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Polar Capital Holdings withdrew a net $1.4B in Q2 2024, closing 31 positions and reducing 109 holdings. Its most notable exit was Indivior Pharmaceuticals, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in First Solar worth $105M.

  • Polar Capital Holdings's largest Q2 2024 buy was First Solar: 463,764 shares worth $105M.
  • Polar Capital Holdings added most to Broadcom in Q2 2024, an estimated $187M increase.
  • Polar Capital Holdings's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $273M.
  • Polar Capital Holdings fully exited Indivior Pharmaceuticals in Q2 2024, selling an estimated $783M.
  • Polar Capital Holdings's ten largest holdings make up 32% of its $17B portfolio in Q2 2024.
  • Polar Capital Holdings opened 25 new positions and closed 31 in Q2 2024.
  • Polar Capital Holdings's portfolio value fell 11% quarter-over-quarter to $17B.

Based on Polar Capital Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.